Navigation Links
Pediatric Use of ADHD Drug may Affect Developing Brain

The use of Ritalin, a stimulant similar to amphetamine and cocaine which is one of the most prescribed drugs for the attention deficit/hyperactivity disorder (ADHD), by young children may cause long-term changes in the developing brains, according to a study of mice by researchers at Weill Cornell Medical College in New York City.

"The changes we saw in the brains of treated rats occurred in areas strongly linked to higher executive functioning, addiction and appetite, social relationships and stress. These alterations gradually disappeared over time once the rats no longer received the drug," notes the study's senior author Dr. Teresa Milner, Professor of Neuroscience at Weill Cornell Medical College.

She suggests that doctors must exercise a lot of care as they diagnose ADHD and before prescribing Ritalin because the brain changes noted in the study though might be helpful in battling the behaviour disorder, can prove harmful if the drug is given to youngsters with healthy brain chemistry.

In the course of study, published in the Journal of Neuroscience, the researchers injected week-old male rat pups with Ritalin twice a day during their more physically active night-time phase. The animals continued receiving the injections up until they were 35 days old.

"Relative to human lifespan, this would correspond to very early stages of brain development. That's earlier than the age at which most children now receive Ritalin, although there are clinical studies underway that are testing the drug in 2- and 3-year olds," explains Jason Gray, a graduate student in the Program of Neuroscience and lead author of the study.

The researchers first looked at behavioural changes in the treated rats, and discovered that Ritalin use was linked to a decline in weight. In the "elevated-plus maze" and "open field" tests, rats examined in adulthood three months after discontinuing the drug displayed fewer signs of an
'"/>




Page: 1 2 3

Related medicine news :

1. Support Services found to Dramatically Impact Pediatric Health Care
2. Pediatricians differ in their opinion of child abuse
3. New Treatment Discovered For Pediatric Cholera
4. Pediatricians Need To Talk To Parents Of Overweight Kids
5. A New Diagnostic Approach To Pediatric Interstitial Lung Disease
6. FDA Accords Priority Review For Pediatric Crohns Disease Drug
7. WHO Updates Outdated Pediatric Growth Charts
8. Pediatricians Resignations Cause Concern at Sale
9. Mental Health Providers Can Be Successfully Located With Pediatricians
10. World’s First Pediatric Laparoscopic Liver Surger
11. Pediatric Dental Care Found Wanting

Post Your Comments:
(Date:11/27/2009)... Nov. 27 GSI Group Inc. ... precision technology products and semiconductor s...the Company,s shareholders has been scheduled for ...the meeting will be announced in due course. As p...ition notice from Stephen Bershad, a holder of gre...
(Date:11/27/2009)... Considered a highly ris...rs ago, solid organ transplantation is now a life-...inary men and women who gathered at the Winspear O...ther from medical centers around the world to cele...splant Institute (BRTI), one of the pioneers of so...
(Date:11/27/2009)...INE, France, Nov. 27 Team Garmin-S... team dedicated to ethical sporting and developing...ed today that it will become Team Garmin-Transitio...ew sponsor of the team. Transitions Optical is the... offering the most advanced photochromic technolog...
(Date:11/27/2009)...-emission vehicles may reduce future disease burde...HealthDay News) -- Encouraging city dwellers to wa...uch greater public health benefits than increased ...ve found. , The study compared the projected he...nsport scenarios for London, England, and Delhi, I...
(Date:11/27/2009)...yant Health™ announced today that Spectrum H...aumaCad Enterprise orthopedic templating solution ... (PRWEB) November 27, 2009 -- ... Health (Grand Rapids, Michigan) has licensed its ...n and its TraumaCad Extend workflow solution, to a...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3
...Percent for the Year , , PITTSBURGH, Feb. 26 MSA... the year ended December 31, 2008 were $1,134.3 mi...rease of $144.0 million, or 15 percent. Net incom...lion, or $1.89 per basic share, for 2007. Net inc...
... Feb. 26 Accuray Incorporated,(Nasdaq: ARAY ), ...y announced,highlights from the clinical and techn...Users, Meeting, which was held February 4-7, 2009,...otic,Radiosurgery System for the non-invasive trea...
... Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to...ant purchase order for the MammoView(TM) line of s...tal in Connecticut. The Waterbury Hospital, the c...he Joint Commission on the Accreditation of Health...
...ss, more peace after sessions, study finds , ...n improve the emotional health of breast cancer pa...gh levels of stress and distress that many women w...ad researcher Suzanne Danhauer, of the Wake Forest...
.... 26 Garry W. Rogerson, Chairman and CEO of Varia...s Capital Global Healthcare Conference in Miami on...ime. , , A live webcast of the presentation will ...ived replay will be available to the public from V...
...iced Nonadhesive Ventral Hernia Meshes Climbs in L...up , , WALTHAM, Mass., Feb. 26 According to Mill...n Markets for Hernia Repair Devices 2009 repo..., lower risk of infection, and lower recurrence ra...
Other Medicine News:Health News:MSA Announces Record Fourth Quarter and Full Year Sales 2Health News:MSA Announces Record Fourth Quarter and Full Year Sales 3Health News:MSA Announces Record Fourth Quarter and Full Year Sales 4Health News:MSA Announces Record Fourth Quarter and Full Year Sales 5Health News:MSA Announces Record Fourth Quarter and Full Year Sales 6Health News:MSA Announces Record Fourth Quarter and Full Year Sales 7Health News:MSA Announces Record Fourth Quarter and Full Year Sales 8Health News:Clinical Evidence Grows in Support of CyberKnife Treatment for Intracranial and Extracranial Tumors 2Health News:Clinical Evidence Grows in Support of CyberKnife Treatment for Intracranial and Extracranial Tumors 3Health News:Clinical Evidence Grows in Support of CyberKnife Treatment for Intracranial and Extracranial Tumors 4Health News:Solos Endoscopy, Inc. Receives Purchase Order from Major Connecticut Hospital for the MammoView(TM) 2Health News:Yoga May Bring Calm to Breast Cancer Treatment 2Health News:Latin American Market for Hernia Repair Devices Achieving Double-Digit Growth 2
(Date:11/27/2009)...KE CITY, Nov. 27 Booth -...(NYSE: VAR ), a premier supplier of X-ray tubes ...it its full range of detectors at the RSNA Annual ...er 3, 2009. Varian will also be exhibiting X-ray ... specialized cancer treatment technologies. ,,...
(Date:11/26/2009)...ESBURG, South Africa, Nov. 26 The ...the Year Award in the Generic Pharmaceutical Marke...d. ,, (Logo: http://www.newscom.com/cgi-bin/pr...Year Award, the following criteria were used to be...petitors: growth strategy and implementation, degr...
(Date:11/25/2009)...D, Colo., Nov. 25 Heska ... of advanced diagnostic and specialty products t...nts with Roche Diagnostics Corporation for the sup...es for the veterinary market. ,, (Logo: ht...GO ) ,, "Heska and Roche share the same passion...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Sensor biochips could aid in cancer diagnosis and treatment 10469 1Sensor biochips could aid in cancer diagnosis and treatment 10469 2Sensor biochips could aid in cancer diagnosis and treatment 10469 3Harvard scientists bend nanowires into 2 D and 3 D structures 14571 1Harvard scientists bend nanowires into 2 D and 3 D structures 14571 2Widely used virus assay shown unreliable when compared to other methods 10467 1Widely used virus assay shown unreliable when compared to other methods 10467 2
...presented at the 90th annual Endocrine Society mee...ected by moderate to severe vaginal ...Mich, June 16 QuatRx Pharmaceuticals today,announ...al Phase 3 clinical,trial of Ophena(TM) (ospemifen...toms of vulvovaginal atrophy, a common condition a...
...lished in the Journal of the American Society of H...giotensin II reversed vascular ... A new study published in the,current Journal of t...hat,the hypertension treatment olmesartan medoxomi...arteries that occurs in patients with hypertension...
Other Medicine Technology:Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy 2Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy 3Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy 4New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 2New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 3New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 4New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 5New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 6New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 7New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 8New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering 9
...choices for finishing. The first choice was to pro...eant longer delay to deliver the order. The altern...eant a substantial investment when additional offi...pace and employee training. TOPscan Remote Tracing...
...rate, and reliable tests of a wide variety of visu...ditions for viewing far point test charts at 5 met...est charts at 30cm (12"). The SS-3, which is very ...an be interchanged as required. The tests show, fo...
Topcon OM-B1 Opthalmometer
... standard in powerful imaging software, and a Comp...ble an easy to use color fundus screening package....gital imaging software with Topcons Non-Mydriatic ...ghly accurate color-digital retinopathy screenings...
Medicine Products: